Hyaluronic Acid (HA)Bioport Crosslink 2%
Sterile viscoelastic solution composed of two cross-linked biological polymers, sodium hyaluronate and sodium chondroitin sulfate, administered by intra-articular injection.
Directions
Acts as a viscoelastic supplement or as a substitute for synovial fluid in the knee joint. Symptomatic treatment of mild to severe osteoarthritis of the knee.
Properties
A single injection per treatment.
Supplied in a Becton Dickinson prefilled glass syringe.
Highly concentrated product:
60 mg hyaluronic acid per syringe with chondroitin for cartilage tissue.
Effects
- Pain relief
- Improved joint mobility
- Cartilage protection
Application
A single injection
A single injection of the product restores joint protection through optimal lubrication and shock absorption, while significantly improving the symptoms associated with osteoarthritis.